M. Inada

Pharmacokinetic Study of S-1 in Patients in Whom Inulin Clearance Was Measured

Y. Ando, Y. Fujimoto, M. Hiramatsu, 2012, Oncology.

Prospective evaluation of corrected QT intervals and arrhythmias after exposure to epirubicin, cyclophosphamide, and 5-fluorouracil in women with breast cancer.

T. Murohara, Y. Inden, K. Kitagawa, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes.

K. Kitagawa, K. Kawada, Y. Ando, 2010, International journal of clinical pharmacology and therapeutics.

The feasibility study of docetaxel in patients with anaplastic thyroid cancer.

Y. Ando, T. Imai, H. Arima, 2010, Japanese journal of clinical oncology.

Pharmacokinetic analysis of carboplatin in patients with cancer who are undergoing hemodialysis

Y. Hasegawa, Y. Ando, Y. Sasaki, 2010, Cancer Chemotherapy and Pharmacology.

Phase I dose-escalating study of panobinostat (LBH589) Administered intravenously to Japanese patients with advanced solid tumors

Y. Ando, H. Tanii, S. Oizumi, 2012, Investigational New Drugs.

EXTRAVASATION OF PEGYLATED-LIPOSOMAL DOXORUBICIN: FAVORABLE OUTCOME AFTER IMMEDIATE SUBCUTANEOUS ADMINISTRATION OF CORTICOSTEROIDS

Y. Ando, K. Kitagawa, T. Shibata, 2012, Nagoya journal of medical science.